Literature DB >> 29138249

Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity.

Ersilia M DeFilippis1, Javed Butler1, Muthiah Vaduganathan2.   

Abstract

Entities:  

Keywords:  cardiomyopathies; death, sudden, cardiac; defibrillators, implantable; heart failure

Mesh：

Substances：

Year:  2017        PMID： 29138249      PMCID： PMC5777623          DOI： 10.1161/CIRCHEARTFAILURE.117.004478

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  13 in total

Review 1.  ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.

Authors:  Andrea M Russo; Raymond F Stainback; Steven R Bailey; Andrew E Epstein; Paul A Heidenreich; Mariell Jessup; Suraj Kapa; Mark S Kremers; Bruce D Lindsay; Lynne Warner Stevenson
Journal:  Heart Rhythm       Date:  2013-03-07       Impact factor: 6.343

2.  Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.

Authors:  Christopher M O'Connor; Alan B Miller; John E A Blair; Marvin A Konstam; Patricia Wedge; Maria C Bahit; Peter Carson; Markus Haass; Paul J Hauptman; Marco Metra; Ron M Oren; Richard Patten; Ileana Piña; Sherryn Roth; Jonathan D Sackner-Bernstein; Brian Traver; Thomas Cook; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

3.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

Review 4.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  J Am Coll Cardiol       Date:  2018-08-16       Impact factor: 24.094

5.  Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.

Authors:  Marie Bayer Elming; Jens C Nielsen; Jens Haarbo; Lars Videbæk; Eva Korup; James Signorovitch; Line Lisbeth Olesen; Per Hildebrandt; Flemming H Steffensen; Niels E Bruun; Hans Eiskjær; Axel Brandes; Anna M Thøgersen; Finn Gustafsson; Kenneth Egstrup; Regitze Videbæk; Christian Hassager; Jesper Hastrup Svendsen; Dan E Høfsten; Christian Torp-Pedersen; Steen Pehrson; Lars Køber; Jens Jakob Thune
Journal:  Circulation       Date:  2017-09-06       Impact factor: 29.690

6.  Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.

Authors:  Stephen J Greene; Adrian F Hernandez; Allison Dunning; Andrew P Ambrosy; Paul W Armstrong; Javed Butler; Lukasz P Cerbin; Adrian Coles; Justin A Ezekowitz; Marco Metra; Randall C Starling; John R Teerlink; Adriaan A Voors; Christopher M O'Connor; Robert J Mentz
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

7.  Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.

Authors:  Maria Ansari; Michael G Shlipak; Paul A Heidenreich; Denise Van Ostaeyen; Elizabeth C Pohl; Warren S Browner; Barry M Massie
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

8.  Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.

Authors:  Gregory A Roth; Jeanne E Poole; Rebecca Zaha; Weiping Zhou; Jonathan Skinner; Nancy E Morden
Journal:  J Am Coll Cardiol       Date:  2016-03-08       Impact factor: 24.094

9.  Declining Risk of Sudden Death in Heart Failure.

Authors:  Li Shen; Pardeep S Jhund; Mark C Petrie; Brian L Claggett; Simona Barlera; John G F Cleland; Henry J Dargie; Christopher B Granger; John Kjekshus; Lars Køber; Roberto Latini; Aldo P Maggioni; Milton Packer; Bertram Pitt; Scott D Solomon; Karl Swedberg; Luigi Tavazzi; John Wikstrand; Faiez Zannad; Michael R Zile; John J V McMurray
Journal:  N Engl J Med       Date:  2017-07-06       Impact factor: 91.245

10.  Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras.

Authors:  Richard M Cubbon; Christopher P Gale; Lorraine C Kearney; Clyde B Schechter; W Paul Brooksby; Jim Nolan; Keith A A Fox; Adil Rajwani; Wazir Baig; David Groves; Pauline Barlow; Anthony C Fisher; Phillip D Batin; Matthew B Kahn; Azfar G Zaman; Ajay M Shah; Jon A Byrne; Steven J Lindsay; Robert J Sapsford; Stephen B Wheatcroft; Klaus K Witte; Mark T Kearney
Journal:  Circ Heart Fail       Date:  2011-05-11       Impact factor: 8.790
View more
  8 in total

1.  Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial).

Authors:  Muthiah Vaduganathan; Ravi B Patel; Robert J Mentz; Haris Subacius; Neal A Chatterjee; Stephen J Greene; Andrew P Ambrosy; Aldo P Maggioni; James E Udelson; Karl Swedberg; Marvin A Konstam; Christopher M O'Connor; Javed Butler; Mihai Gheorghiade; Faiez Zannad
Journal:  Am J Cardiol       Date:  2018-04-11       Impact factor: 2.778

2.  Dying is not what it used to be! Impact of evolving epidemiology and treatment on mode of death in heart failure.

Authors:  Ravi B Patel; Anju Nohria; Javed Butler; Muthiah Vaduganathan
Journal:  Eur J Heart Fail       Date:  2019-08-13       Impact factor: 15.534

3.  A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.

Authors:  Peter Winkle; Steven Goldsmith; Michael J Koren; Serge Lepage; Jennifer Hellawell; Ashit Trivedi; Kate Tsirtsonis; Siddique A Abbasi; Allegra Kaufman; Richard Troughton; Adriaan Voors; Jean-Sebastien Hulot; Erwan Donal; Navid Kazemi; Joel Neutel
Journal:  Cardiovasc Drugs Ther       Date:  2022-04-23       Impact factor: 3.727

Review 4.  Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?

Authors:  Abhinav Sharma; Subodh Verma; Deepak L Bhatt; Kim A Connelly; Elizabeth Swiggum; Muthiah Vaduganathan; Shelley Zieroth; Javed Butler
Journal:  JACC Basic Transl Sci       Date:  2022-03-02

5.  Cost-Effectiveness of Earlier Transition to Angiotensin Receptor Neprilysin Inhibitor in Patients With Heart Failure and Reduced Ejection Fraction.

Authors:  Andrew D M Grant; Derek S Chew; Jonathan G Howlett; Robert J H Miller
Journal:  CJC Open       Date:  2020-06-04

Review 6.  Left ventricular reverse remodelling and its predictors in non-ischaemic cardiomyopathy.

Authors:  Tomas Hnat; Josef Veselka; Jakub Honek
Journal:  ESC Heart Fail       Date:  2022-04-18

7.  The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies.

Authors:  Stephanie Poon; Benjamin Leis; Laurie Lambert; Kendra MacFarlane; Kim Anderson; Claudia Blais; Catherine Demers; Justin A Ezekowitz; Nathaniel M Hawkins; Douglas S Lee; Gordon Moe; Roopinder K Sandhu; Sean A Virani; Stephen Wilton; Shelley Zieroth; Robert McKelvie
Journal:  CJC Open       Date:  2022-08-12

8.  Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.

Authors:  Johanna Mueller-Leisse; Johanna Brunn; Christos Zormpas; Stephan Hohmann; Henrike Aenne Katrin Hillmann; Jörg Eiringhaus; Johann Bauersachs; Christian Veltmann; David Duncker
Journal:  Sensors (Basel)       Date:  2022-03-05       Impact factor: 3.576
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.